Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $9.5

Benzinga · 5d ago
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and raises the price target from $9 to $9.5.